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Abstract 
 
Nuclear autophagy (nucleophagy) has been described as a cellular metabolic response by 
which nuclear material is actively degraded after stressors, such as nuclear damage or the onset 
of tumorigenesis. Here we describe nucleophagy as a process distinct from traditional 
macroautophagy in human cell lines. We found that although nuclear localization of LC3 is not 
dependent on particular nuclear importins, knockdown of nuclear importins (causing nuclear 
stress) can induce a nuclear autophagic response. Our characterization of nucleophagy was 
facilitated by chemical modulation of the process via two compounds discovered previously in a 
high content analysis. These small molecules bidirectionally regulate nuclear autophagy in 
human renal, pancreatic, and bladder cell lines. One molecule (NSC31762 or DTEP) enhances 
nuclear autophagic puncta and increases lysosomal targeting of LC3. Another molecule 
(NSC279895 or DIHI) reduces the nuclear localization of LC3. Finally, we applied these 
chemical tools in the setting of aneuploidy driven nuclear stress. The compound DIHI, shown to 
reduce nuclear autophagic puncta, was able to revert cells from aneuploidogen-induced 
phenotypes, possibly restoring homeostasis.  These new tools will allow for a deeper exploration 
of nucleophagy, and could serve as proof-of-principle in guiding new therapies for diseases 
involving nuclear stress.  
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Introduction 
 
Macroautophagy: The Cell’s Recycling System    
Autophagy is the systematic recycling and destruction of cellular components, such as 
ineffectual organelles, and is a basal process in nearly all eukaryotes (Levine and Klionsky). 
Evolved as an adaptation of eukaryotic cells to survive during starvation conditions, autophagy 
allows for nutrients otherwise inaccessible within the cell to be sacrificed for survival (Rogov et 
al.). Research in the 1960’s hinted at an early mechanism for membrane recycling in the 
lysosome with an emphasis on substrate specificity (Yang and Klionsky). It wasn’t until the 
1990’s that molecular biology techniques and theories were applied in the setting of autophagy, 
resulting in the rapid expansion of autophagy research and the culmination in the 2016 Nobel 
Prize in Physiology or Medicine. Work in the Ohsumi lab revealed morphological similarities 
between mammals and yeast, ultimately elucidating the first autophagy gene ATG1 through 
genetic screens of yeast mutants (Tsuboi). Macroautophagy is traditionally considered to be a 
nonselective process; an overview of the steps of macroautophagy are provided in Figure 1. 
Recent specific forms of selective autophagy have been described, however, and each has 
maintained certain core Atg proteins necessary for the main molecular machinery required for 
autophagosome formation (Xie and Klionsky). The implication of autophagy as a basal process 
necessary for development and survival, as well as its role in the progression of many diseases, 
highlights the need for further research to understand the intricacies of this phenomenon.  
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Figure 1. Mechanism of macroautophagy Graphical representation of the general 
macroautophagy pathway. ‘Cargo’ (red) is engulfed by a structure called a phagophore initiated 
by the ULK1/2 complex among other proteins. Proteins, including ATG9 and LC3 (green) help 
to form the autophagosome, which completely surrounds the cargo. This structure can then either 
fuse with an endosome (and eventually a lysosome) or a lysosome (purple) directly, forming the 
autophagosome where hydrolases degrade the cargo and recycle components in the cytosol 
(Carneiro and Travassos).   
 
 
Basal autophagy is generally defined as a homeostasis mechanism and the primary source 
of essential nutrients, where induced autophagy is not necessarily present; this is under normal 
conditions and short, non-fatal periods of starvation (Mizushima);(Codogno and Meijer). 
Particularly in the brain, autophagy may be initiated to counteract the detrimental effects of 
starvation and hypoxia, converting amino acid energy into essential glucose to fuel critical 
tissues and erythrocytes (Codogno and Meijer). Light chain 3 (LC3), a subunit of microtubule-
associated protein 1A (MAP1A) and MAP1B, is an invaluable marker of autophagy as it 
associates with the autophagic machinery upon initiation of autophagy. Alongside yeast proteins 
Atg8/Apg8/Aut8, these markers are associated with a ubiquitination-like conjugation system 
which mediate membrane formation (Ugolino et al.). Ubiquitin-like proteins (UBLs) are 
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recruited by autophagy receptors to the material the cell needs to degrade, resulting in the 
association and activation of core machinery (Rogov et al.).  
 
Selective Autophagy 
 
Selective forms of autophagy have now been described with high specificity and 
regulation, and have been found to span cellular compartments such as the mitochondria 
(mitophagy), the endoplasmic reticulum (ER-phagy), and the peroxisome (pexophagy) (Figure 
2) (Gomes and Scorrano; Kraft, Reggiori, and Peter; Mizushima). Of recent interest are 
autophagy pathways that have been infrequently observed but seem to be implicated in a 
multitude of disease systems. Nucleophagy, or degradation of nuclear material via an autophagic 
pathway, has been identified as a unique process in yeast and mammalian systems (Mijaljica and 
Devenish).  Recent studies have confirmed the existence of nucleophagy and have correlated it 
with diverse cellular processes, including epidermal differentiation (Akinduro et al.), senescence 
after DNA damage (Dou et al.), and the clearing of extra-nuclear DNA alongside accumulated 
nuclear envelope proteins (Park et al.; Mijaljica, Prescott, and Devenish).  However, the set of 
conditions under which nucleophagy is activated, the identification of the degraded nuclear 
substrates, and the mechanism of transport of LC3 into the nucleus and export of nuclear 
materials are still under investigation.   
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Figure 2. Selective Autophagy  Selective autophagy serves to recycle many different 
components of the cell, including portions of the nucleus (nucleophagy), the peroxisome 
(pexophagy), mitochondria (mitophagy), endoplasmic reticulum (ER-phagy), pathogens 
(xenophagy), though this list is not exhaustive. Each is associated with distinct pathways and 
machinery.  
 
The ER-associated degradation (ERAD) pathway is recognized as the main mechanism 
by which potentially dangerous, stress-inducing misfolded proteins are mediated. ERAD targets 
accumulated unfolded proteins, exporting them via a translocon, where they are subsequently 
degraded by the proteasome. Autophagy is implicated as a means by which substrates can be 
degraded if the ERAD system is overwhelmed (Yorimitsu et al.). ER-phagy seems to serve as a 
backup plan for the unfolded protein response, essentially expanding the function of the ER 
under conditions of high demand (Schuck, Gallagher, and Walter). ER-phagy can be defined as a 
subset of autophagy, primarily due to a dependence on core autophagy machinery, specifically 
Atg9 (Lipatova and Segev), as well as the fact that it is ER-specific and is similar to 
microautophagy, mediated by direct lysosomal engulfment (Yorimitsu et al.). This form of 
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specific autophagy may provide some insight into the mechanistic differences between 
nucleophagy and macroautophagy, the details of which are unclear.  
 
Nucleophagy and the Stress Response 
Like other forms of autophagy, nucleophagy appears to be a stress response system.  It is 
recognized that the nucleus has complex pathways in place which respond to stress or damage 
(Mah, El-Osta, and Karagiannis; Kose, Furuta, and Imamoto; Biamonti and Vourc’h).  Normally, 
proteins with a nuclear function enter and exit the nucleus mediated by transporters that are 
members of the importin/exportin family (Stewart). Disruption of nuclear transport through the 
nuclear pore complex leads to nuclear stress and subsequent disease phenotypes, including age-
related impairments, cancer, and neurodegeneration (Freibaum et al.; D’Angelo et al.; Zhang et 
al.; Hirano et al.). Here we investigate whether nucleophagy is upregulated in response to nuclear 
transport stress. 
The loss or malfunction of autophagy can lead to cellular damage and the onset of disease 
(Wong, Cheung, and Ip). When DNA damage occurs in tandem with loss of autophagic function, 
the result is increased cell death and increased risk of tumorigenesis (Mizushima and 
Yoshimori).  Indeed, it is known that in the setting of tumorigenic stress, selective autophagy 
may clear damaged DNA, activated oncogenes, and proteotoxic aggregates, stabilizing cancer 
cells, though the exact mechanisms by which these substrates are recognized remains elusive 
(Santaguida et al.). Tumors able to survive p53-induced apoptosis exhibit increased levels of 
autophagy, where cells found at the core of the tumor are protected from necrosis due to nutrient-
limited conditions and oncogenic stress (Amaravadi et al.). Macroautophagy has been observed 
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to aid in cell survival up to weeks after induced nutrient-limiting stress; while survival increases, 
metabolic upregulation of glycolysis impairs the cell’s ability to proliferate (Klionsky et al.).  
Autophagy is a critical component of the overall induced stress-response necessary for 
repair to occur after the onset of disease, inflammation, and the cell’s initiation of apoptosis. On 
a macro level, autophagy has the potential to limit genome damage during tumorigenesis 
(Mizushima). Bcl-2 proteins, specifically Bcl-2, Bcl-xL, and Mcl-1, are known to be regulators 
of not just apoptosis, but autophagy as well, as has been observed in Bcl-2 homolog Beclin 1 
(Marquez and Xu). Beclin 1 is known to inhibit tumorigenesis and increase autophagy; loss of 
this gene is implicated in human breast carcinomas (Liang et al.). Treatment of diseases like 
cancer may be augmented by the inhibition of Blc-2, which would initiate apoptotic pathways. 
Natural killer (NK) cells are able to induce autophagy both promoting a recovery and repair 
response while simultaneously potentially promoting the onset and survival of cancer (William J 
Buchser, Thomas C Laskow). 
A more extreme example of a stress phenotype is whole-chromosomal abnormality that 
changes the numerically standard ploidy of a cell. Cells unable to carry out autophagy exhibit 
lower survival, yet simultaneously show an increase in mutation rate alongside the induction of 
aneuploidy (Mathew et al.). Suppression of DNA damage via autophagy may also serve as a 
tumor suppressant mechanism.  It has now been shown that oncogenic mutations and aneuploidy 
can trigger nucleophagy as a mechanism for the destruction of essential structural proteins 
(nuclear lamin B1). This ultimately induces cellular senescence and prevents further damage to 
the organism (Dou et al.).  Malignant cancers frequently exhibit aneuploidy (Torres, Williams, 
and Amon), raising questions as to whether these cells can manipulate autophagy in their favor. 
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We seek to better understand the interplay between nucleophagy and nuclear stress in the setting 
of aneuploidy. 
Here, we utilize two new chemical modulators to investigate the dynamics of 
nucleophagy.  Given that nuclear autophagic puncta are infrequently observed in untreated 
cultured cells, these modulators increased their expression allowing for tangible characterization 
of the process. In this state, the autophagic protein LC3 localizes to regions of the nucleus with 
low DNA content (nuclear holes), and on occasion with large amounts of extra-nuclear DNA 
(micronuclei). Our results suggest that nuclear LC3 localization is increased under nuclear stress 
induced by knockdown of nuclear import proteins. Finally, we use the chemical modulators to 
investigate the functional role of nucleophagy to mitigate nuclear stress in the setting of 
aneuploidy. 
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Methods 
 
High Content Chemical Screening Assay 
 Medium throughput, high-content screening of 1,600 chemical compounds (NCI DTEP 
diversity set IV) identified molecules that modulate nucleophagy. 786-0 cells (described below) 
were cultured on 96-well plates and exposed to either a vehicle (DMSO or PBS) or treatment 
condition at 10µM. Border wells were excluded to control for well effects. Media was replaced 
after 4 hours of incubation with the compound, and cells were subject to fixing and staining after 
18 hours. Between 2 and 4 biological replicates (discrete passages) were analyzed. Plate layout 
for the secondary screen is included in Supplemental Figure 1.  
 High content screening (HCS) allowed for automated measurement of biological cellular 
components using automated microscopy. HCS is commonly used when looking at large 
numbers of drugs in screenings where cellular activity cannot be measured by a single variable. 
This results in a large amount of data that must be manipulated before further assessment can be 
completed. Further, the cellular model must be both reproducible and consistent (William J 
Buchser, Thomas C Laskow).  
 This high content screen was conducted with medium throughput rather than high 
throughput, providing evidence that a large-scale chemical screen can be conducted using 
affordable machinery and technical skill, though the overall pipeline may be slowed due to the 
smaller number of experiments that can be conducted at any given time. TIBCO Spotfire, a third-
party analysis program, helped in the analysis of molecules that directionally regulate LC3 
localization in the nucleus.  
 
	 14	
Chemical Validation and Normalization 
To ensure the validity of the effects of the compounds, a correlation analysis was run 
between the assay plates and chemical source plate. Every compound was tested for correlation 
among two assay plates; high correlation was a strong indicator of accuracy. Plate effects were 
controlled for during analysis by rotating one of the two assay plates 180 degrees, overlaid on the 
other plate. In doing so, compounds were no longer aligned and should have had no correlation; 
any observed correlation was due to plate effects (Supplemental Figure 2). Using these control 
methods, we determined that obvious compound effect correlations existed among the data, and 
there were no observable plate effects. Covariance analysis provided insight into the variables 
that were most effected by compounds; notably, cytoplasmic LC3, nuclear LC3, nuclear area, 
and nuclear holes per nuclei were the four most correlated parameters.  
Cell Culture and Transfection 
Human cancer cell lines from ATCC (Manassas, VA) were used: 786-0 (CRL1932), 
CAKI-1 (HTB46), RCC4 (CVCL0498), pancreatic cell line PANC-1 (CRL1469), and human 
bladder cancer cell line T-24 (HTB-4). Cells were cultured in DMEM (Thermofisher 11995-065) 
supplemented with FBS (Thermofisher 26140079) and PenStrep (Thermofisher 15140-122) in a 
humidified incubator at 37°C with 5% CO2.  Cells were seeded in 96-well plates at 3,000 cells 
per well in 100µL of supplemented media. Plates were incubated at 37°C for 24 hours prior to 
manipulation.  
 Pre-designed SureSilencing™ short hairpin RNA (shRNA) plasmids from SABioscience 
(Frederick, MD) were used in order to target specific mRNA of importin β1 (KPNB1), importin 
7 (IPO7), importin 8 (IPO8), and a scrambled negative control (Roggero et al.).  For the time 
lapse experiments, we used the RFP-GFP-LC3B plasmid (Kimura, Noda, and Yoshimori) (gift 
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from Earl Godfrey).  At 70% confluency, we transfected cells with shRNA plasmids or the RFP-
GFP-LC3B plasmid using Lipofectamine 2000 (Thermofisher 11668-027) and the 
manufacturer’s protocol. Ten hours after transfection, media was replaced and the cells were 
treated with the chemical compounds.  After three hours, the compounds were rinsed out with 
fresh media, and the cells were incubated for 24 hours at 37°C.  
Immunofluorescence  
Following treatment and incubation, cells were fixed with 3.2% paraformaldahyde 
(ThermoFisher) in PBS. Plates were blocked and permeabilized in one step using bovine serum 
albumin (BSA) and 0.1% Triton X-100 in PBS at room temperature for 1 hour (both from 
Sigma-Aldrich). Antibodies were diluted in a blocking mixture consisting of a 1:1 ratio of PBS 
and BSA. Nuclear material was stained with Hoechst (ThermoFisher, H3570) at a 1:5000 
dilution and endogenous LC3 was tagged with an LC3B/MAP1LC3B primary antibody 
(ThermoFisher, L10382) used at a dilution of 1:500 for 72 hours at 4°C. After incubation, the 
primary antibody was rinsed three times with PBS then Alexa Fluor 546-tagged goat anti-rabbit 
IgG secondary antibody (ThermoFisher, A-11035) was add at a 1:1250 dilution and incubated 
for 1 hour before a final 3x rinse with PBS.  
Microscopy  
Endpoint experiments were visualized using a Nikon inverted epifluorescence 
microscope. A 40x DIC objective was used with the DAPI (400-800 msec exposure) and TRITC 
(800-1600 msec exposure) filters.  Microscopy was semi-automated such that four different 
images were acquired in each well (using multi-point) and the focal plane for each well was 
determined by eye (Supplemental Figure 3).  
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For confocal microscopy, cells were cultured on glass coverslips (#1.5), treated for a 
period of 4 hours, and subsequently fixed and stained after 24 hours. Coverslips were inverted 
and mounted onto glass slides using Fluoromount (Sigma-Aldrich). A Nikon confocal 
microscope was used to acquire Z-stacks at an average of 8-10 steps over a range of 6-9µM (top 
to bottom of the nucleus). The pinhole was set to 1.7 A.U., while laser power was held constant 
across samples.  
For time-lapse experiments, 786-0 cells were transfected with an RFP-GFP-LC3 plasmid. 
After 8 hours, DMEM was replaced with FluoroBright DMEM (Thermofisher) and cells were 
treated with nucleophagy-modulating compounds.  Temperature, CO2, and humidity were kept 
constant in a live cell chamber.  Images were captured via confocal microscopy at 20 minute 
intervals over 16 hours using a pinhole of 1.2 A.U. and 4x line averaging.  
Image Analysis  
Images were processed in FIJI/ImageJ (Schneider, Rasband, and Eliceiri).  ImageJ was 
used to create maximum intensity projections of confocal z-stacks, z-slice views (dynamic 
reslice), and plot intensity profiles. Large 2x2 tiled images gathered from the inverted 
microscope were split into four by a script running in ImageJ.  Open-source software 
CellProfiler was used for automated image analysis (Kamentsky et al.). The CellProfiler pipeline 
identified individual nuclei via Mixture of Gaussians (MoG) thresholding, which then allowed 
for analysis of intensity, localization, and prevalence of LC3 and nuclear material within the cell. 
The image-based flat files returned from CellProfiler were compiled, and Spotfire DecisionSite 
(Tibco Spotfire) was used to manually “quality control” the tracing by examining each of the 
traced wells for errors.  
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Images containing errors in tracing, those containing 2 cells or fewer per image, and 
those with obvious artifacts were excluded from analysis.  The scripts for ImageJ and 
CellProfiler are included in the Supplement.  Images that contained fewer than 3 cells per 
image, contained an error in tracing, or contained other artifacts were omitted from the overall 
analysis.  When replicates from different plates (often from different cultures and days) were 
analyzed, they were first normalized so that the global mean of all the wells for all parameters 
studied were equal to 1 (by dividing by the global mean for each plate). To analyze the 
correlation between the two channels in cells, the Coloc2 program in ImageJ/FIJI was used on 
two slices manually selected from a z-stack of confocal images.  
Protein Analysis 
Knockdown of importin β1, importin 7, and importin 8, compared to scrambled control 
shRNA, was validated by western blot by Dylan Zhang of Lizabeth Allison’s lab as previously 
described (Roggero et al.).  Briefly, 786-0 cells in 6-well plates were transfected with sets of four 
shRNA plasmids (SABioscience, Frederick, MD) and lysed 24 hours post-transfection. 
Antibodies were used with the following concentrations: anti-GAPDH (Santa Cruz 
Biotechnology Inc, Dallas, TX), 1:5000; anti-importin β1 (Santa Cruz), 1:2000; anti-importin 7 
(Abcam, Cambridge, MA), 1:1000; anti-importin 8 (Abcam), 1:250.  Seven independent 
replicates of each importin knockdown were completed from different cultures across distinct 
days. 
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Results 
Compounds that Manipulate Nuclear Autophagic Puncta 
Functional experiments analyzed 1600 chemical compounds for nuclear autophagic 
phenotypes (David Heo, Likhitha Kolla, 2017). Compounds were screened for modulation of 
nucleophagic activity, quantified by the average abundance of nuclear LC3 puncta. Of 1,309 
compounds, two were able to induce distinct phenotypes. Of the 1600 compounds tested, 1309 
passed quality control (QC), ranked by the replicate average Nuclear LC3, and 17 showed a 
notable increase in nuclear LC3 (Figure 3). 11 of these hits were considered significant after 
normalization, and one of the molecules was able to decrease nuclear LC3. Five compounds 
affected the number of holes per nuclei as well as the nuclear intesisity: four had a significant 
increase in holes (NSC60785, NSC126757, NSC279895 and NSC236246) and one had a 
significant decrease (DiHi).  
A wide range of existing uses were found for some of the molecules that affected nuclear 
LC3. The two drugs described in this paper that affected an aneuploidy phenotype (NSC31762 
and NSC279895) are notable in their potential to target relevant pathways. NSC31762 is 
structurally similar to thyroid hormone, and the phenyl moiety of NSC279895 may allosterically 
interact with the thryroid hormone receptor (THR) (Figure 4).  
NSC367306, similar in structure to Benzoylurea, and NSC634396, similar to 
Benzothiazin, have been reported to have possible anti-cancer tendencies. Benzoylurea has 
previously been used as an insecticide, while Benzothiazin has reported anti-cancer activity. 
NSC636717 and NSC126757 are reported Shiga toxin inhibitors. NSC179818, related to 
chloroacridine, has been reported to have anti-inflammatory and anti-malarial effects. 
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NSC109128 is a sterol like compound that has been shown as an anti-viral in the setting of 
Hepatitis C. 
The first of the molecules increased nuclear LC3 intensity; NSC31762, 2,6-Diiodo-4- [2-
(1,3,3-Trimethylindol-2-ylidene) Ethenyl] Phenol (abbreviated DTEP).  Nuclear LC3 in cells 
exposed to DTEP at increasing concentrations (Figure 5A) had a significantly positive 
regression between DTEP concentration and LC3 enrichment within the nucleus (Linear 
regression, p =1.5x10-5, F=58).  DTEP is itself fluorescent at 590 nm, so may also be used as a 
tracer.  The second compound decreased nuclear LC3 intensity; NSC279895, 1-(2,4-
Dihydroxyphenyl) Heptane-1,2-Dione (abbreviated DIHI).  There was a significant decrease in 
nuclear LC3 intensity as DIHI concentration increased (Figure 5B, Linear regression p=0.0081, 
F=7.8). Seventy additional compounds affected at least one parameter measured, and half were 
selected for further experiments (Figure 10).  
We asked whether DTEP’s striking induction of nuclear punctae was conserved across 
cell types.  Treatment with 20 µM DTEP produced a strong increase in nuclear LC3 across 
multiple cell lines, including renal lines 786-0, and CAKI-1, T-24 bladder cancer, as well as the 
pancreatic line PANC-1 (Figure 5C). In order to determine whether DTEP accelerated 
autophagy, we used the tandem pH-dependent RFP-GFP-LC3 reporter, in which acid sensitive 
GFP is quenched in the setting of the lysosome, leaving only RFP signals as an indicator of 
autophagic activity (Kimura, Noda, and Yoshimori). Treatment with vehicle (DMSO) or DIHI 
showed no significant change in GFP/RFP ratio over the course of an eight-hour period. A 
relative decrease in GFP, however, was observed in both the starvation treatment (PBS), as well 
as the 20µM DTEP treatment (Figure 5D).  The loss of green fluorescence implied an increase 
in degradation of RFP-GFP-LC3 in the lysosome.  Starvation with PBS induced a significant 
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increase in autophagic activity after 8 hours (t-test p=0.037), while the DTEP treatment caused a 
significant drop in the green/red ratio within a single hour (t-test p=4.2x10-6).  We conclude that 
DTEP and DIHI represent new chemical tools to modulate LC3 localization and autophagic flux. 
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Figure 3.  1600-Compound Screening Results. From the initial 1600 compounds, 1309 passed 
quality control (QC). These hits were ranked by nuclear LC3 of the average of two plates A) Plot 
of the ordered QCs against the average nuclear LC3 values. We specifically chose to further 
investigate compounds with Nuclear LC3 values two standard deviations above or below the 
overall mean (indicated by the thick pink line). B) Ranked QCs were plotted against average cell 
densities (y) at point of fixation as an indicator of cell viability. Compounds with low cell 
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densities were considered toxic and omitted from the secondary assay. C) Holes per nuclei.  
Each coordinate represents the average parametric value of two experimental replicates for a QC, 
bars standard deviation  
 
 
 
 
Figure 4. Results from Secondary Screen. Stats for nuclear LC3 intensities and nuclear holes. 
Bolded p-values were still significant after correcting for multiple comparisons by Benjamini 
Hochberg. Red values represent a decreasing correlation while black values represent increasing 
correlations. Empty cells show lack of significance. Select compound morphologies are also 
shown. 
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Figure 5.  Compounds that Enhance and Inhibit LC3 Nuclear Puncta.  A) Increasing 
concentrations (µM) of the compound DTEP  resulted in a significant increase in nuclear LC3 
compared to a DMSO control (Linear regression, p=1.5x10-5). B) Increasing concentrations of 
the compound DIHI results in a significant decrease in nuclear LC3 intensity (p=0.0081).  
Markers represent well average, shadings indicate different biological replicates.  C) 
Nucleophagy induced by DTEP in renal clear cell carcinomas (786-0, CAKI-1), T-24 bladder 
cancer, and pancreatic carcinoma PANC-1. LC3 (red) was found enriched within the nucleus 
(marked by DNA in blue). D) Cells transfected with a tandem RFP-GFP-LC3 sensor were 
monitored for autophagic activity over the course of eight hours. Markers show average ratio of 
green/red fluorescence with standard deviation between cells.  Starvation (PBS) results in an 
increase in red signal (LC3 in the autolysosome, p = 0.037). Cells treated with 10 µM compound 
DTEP exhibit a significant increase in autophagy, especially eight hours after treatment (p = 
0.00011).    
 
Nuclear Autophagic Puncta Represent a Physiologic Intra-Nuclear Process 
Previous examination of the autophagic signature of a number of cancer cell lines 
revealed that renal and pancreatic cells in particular were more likely to reveal nuclear LC3 
puncta under both normal and stress conditions, justifying their use in these experiments 
	 24	
(Buchser et al.). While a fraction of control cells possess nuclear autophagic puncta, it is a 
relatively rare occurrence (Figure 6A black bars). DTEP’s ability to induce nuclear puncta was 
analyzed in both 786-0 cells and PANC-1 over several biological replicates.  DTEP increased the 
fraction of cells with nuclear LC3 by ~50% (% of cells with average nuclear LC3 intensity above 
DMSO control levels, Figure 6A gray bars, t-test, p < 0.0001). 
We next asked how this chemical-induced phenotype compared to other autophagy-
related phenotypes.  786-0 human renal cells were exposed to drug solvent (DMSO), macro-
autophagy was induced using hydroxychloroquine (HCQ), and nuclear puncta were invoked 
using DTEP (as above).  Confocal microscopy confirmed little to no LC3 in the cytoplasm or in 
the nucleus of most control cells (Figure 6B).  When treated with HCQ, cells exhibit nonspecific 
macroautophagy that is most notably extra-nuclear (Figure 6C). There is little to no association 
between nuclear DNA intensity and LC3 intensity within the nucleus; most LC3 remains in the 
cytoplasm, as is seen both in the line scan and in the z-stack. When cells were treated with 
DTEP, prominent nuclear LC3 puncta appeared (Figure 6D). In the representative cell shown, 
LC3 & DTEP were localized to regions of low DNA density, which are referred to as “nuclear 
holes.”   
Presence of LC3 within the nucleus (not above or below) was confirmed using multi-step 
z-stack confocal microscopy. To determine whether the localization of the LC3 within the 
nucleus was consistent in the DTEP condition, a colocalization analysis was performed.  
Twenty-five representative images from biological replicates across three cell lines were 
analyzed. Individual nuclei were analyzed by confocal slice, and the correlation between LC3 
and DNA was slightly lower in DTEP-treated cells than control (Figure 6E; t-test, p = 0.048). 
The variation between cells, however, was high, indicating that colocalization between these 
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nuclear holes and LC3 puncta may depend on the state of nucleophagic flux or other factors.  
 
Figure 6.  LC3 Nuclear-Autophagic Puncta are Phenotypically Distinct from Macro-
autophagic Puncta. A) Markers show % of cells above background levels of nuclear autophagic 
puncta (4 biological replicates each).  Bars demonstrate the average % cells per condition.  The 
presence of DTEP significantly increases the percentage of cells that are positive for nuclear LC3 
between both pancreatic and renal cell lines (p < 0.001, t-test of biologically independent 
replicates). B-D Upper panels are confocal slices on 786-0 cells. A line plot (generated based on 
the solid white line in the upper panels) indicates topographical association between DNA (blue) 
and LC3 (red).  Below the line plot, a scale-matched depth reconstruction (z-stack) is shown.  B) 
786-0 cells treated with DMSO (vehicle) show low autophagic activity and weak topographical 
association.  C) Cells treated with hydroxychloroquine (HCQ) have classic perinuclear 
localization of LC3. D) Treatment with the compound DTEP results in higher concentrations of 
LC3 inside the nucleus.  Line scans show the anti-correlated nature of the DNA and LC3 (with 
LC3 localized to low-DNA “nuclear holes”). E) Nuclear LC3 puncta have variable amounts of 
colocalization with nuclear DNA (p = 0.048, dots represent the LC3-DNA pixel-pixel based 
Pearson’s correlation of individual cells analyzed from 3 different cell lines; white: RCC4, gray: 
786-9, black: CAKI-1).  
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Loss of Importins Induce Nuclear LC3 Localization 
Our hypothesis that disrupting importin-dependent nuclear transport may induce nuclear 
stress and enhance nuclear autophagy was tested in the setting of knockdown of nuclear 
importins β1, 7 and 8. LC3 intensity within the nucleus was measured and compared to a 
scrambled shRNA control. Nuclear LC3 intensity significantly increased among importin β1, 7 
and 8 knockdown cells compared with scrambled shRNA or untreated controls (Figure 7A, 2 
wells each across 4 biologically independent replicates.  ANOVA p=0.000141, f=6.91, post t-test 
p = 0.00045, p = 0.014, p = 0.016 respectively).  These results suggest importins β1, 7, and 8 
don’t directly affect LC3 nuclear localization.  Instead, the loss of importin-mediated nuclear 
transport may have triggered nuclear stress and subsequent nucleophagy.  Knockdown efficiency 
was confirmed via western blot (Figure 7B).  
Confocal microscopy determined whether the localization of LC3 was juxta-nuclear or 
intra-nuclear after importin knockdown (Figure 7C). Importin 7 knockdown resulted in 
prominent intra-nuclear localization of LC3 whereas Importin 8 knockdown had both intra- and 
resulted in more juxta-nuclear LC3. 
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Figure 7. Knockdown of Several Importins Leads to Heightened Nuclear LC3 
Accumulation. A) Average Nuclear LC3 intensity of 786-0 cells after knockdown of importins 
7, 8 and β1, compared with untreated control and scrambled (Sc) shRNA.  Error bars show 
standard deviation. B) Western blots (importins in upper bands and GAPDH in lower bands) and 
densitometric quantifications of knocked down importin 7, 8, and β1 when compared to a 
scrambled shRNA (average and standard deviation of 7 biological replicates). C) Micrographs 
show a maximum projection and two reconstructed “side views” of 786-0 renal cells transfected 
with shRNAs against importin 7, 8 or scrambled shRNAs.  Cells were stained for LC3 (red) and 
DNA (blue).  Importin 7 knockdown cells have the clearest intra-nuclear puncta (especially 
evident when viewed from the side), whereas importin 8 and Sc have both cytosolic and nuclear 
LC3 distribution.  
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Modulating Nucleophagy Can Revert an Aneuploidy Phenotype  
To determine the functional consequences of these nuclear autophagic puncta, the two 
new nucleophagy tuning tools, DTEP and DIHI, were used in an applied physiological process 
associated with nuclear damage.  Similar to previous studies (Dou et al.), we aimed to induce 
aneuploidy by introducing nuclear stress and triggering senescence.  Two aneuploidogens, 
docetaxel and nocodazole, were used to halt normal cell division resulting in subsequent 
aneuploidy and oncogenic stress (Figure 8). 786-0 renal cells were exposed to a gradient of 
docetaxel (up to 3.2 µg/mL) to chemically induce aneuploidy (Hernández-Vargas, Palacios, and 
Moreno-Bueno) (Figure 9A). As the concentration of docetaxel increased, the cell density 
decreased, indicating either cell death or reduced cell division (Linear regression, p=1.02x10-5, 
f=44.8). Furthermore, the average nuclear area increased (p=1.78x10-5), likely indicating 
senescence.  A representative image of an induced aneuploidy nuclear phenotype is shown in the 
middle panel of Figure 9G.  
After optimizing induction of aneuploidy, we asked whether DTEP or DIHI could 
mitigate the effects of docetaxel. 786-0 renal cells were treated with 0.8 µg/mL of docetaxel for 
three hours and then subsequently exposed to a gradient of DTEP (up to 1µM Figure 9B).  In the 
presence of an aneuploidogen induced phenotype, an increased concentration of DTEP resulted 
in a nuclear LC3 increase (bottom panel, p = 0.0047, f=16.7). DTEP was unable to interfere with 
the aneuploidy phenotype, and even minimally contributed to further cell density reduction (4B 
upper panels).  On the other hand, DIHI was able to intercept the docetaxel-related mitotic 
effects (Figure 9C).  786-0 cells pre-treated with docetaxel and increasing concentrations of 
DIHI show a significant increase in cell density (4C upper panel, p=0.0042, f=12.0) and decrease 
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in nuclear area (middle panel, p=0.0043, f=11.9), indicating a reversion of the aneuploidogen-
induced nuclear phenotype. Representative images of nuclei after treatment with docetaxel and 
DIHI are also shown (Figure 9G bottom panel).  
A second aneuploidogen, nocodazole, was used to induce G2/M arrest by interfering with 
microtubule polymerization resulting in polyploidy.  As the concentration of nocodazole was 
increased (up to 30 µg/mL), the cell density decreased while nuclear area increased (Figure 9D, 
linear regression density p=2.9x10-5, f=39.2, area p=0.0067, f=10.4), indicating reduced cell 
division due to mitotic blockade. We then asked whether DTEP or DIHI were able to interfere 
with the effects of nocodazole by exposing 786-0 cells to 15µg/mL nocodazole and a subsequent 
DTEP gradient. DTEP concentration and nuclear LC3 were found to have a positive relationship 
as seen in previous experiments, but DTEP was unable to reverse nocodazole’s phenotypic 
effects, possibly making them more pronounced (Figure 9E). When DIHI was added in the 
presence of 15 µg/mL of nocodazole, there was no significant change in LC3, area, or cell 
density.  We conclude DIHI, which we showed to inhibit nuclear autophagic puncta, protects the 
cells from a docetaxel-induced aneuploidy phenotype.   
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Figure 8.  Chemical induction of aneuploidy.  Histograms showing the distribution of 
individual cells on a scale of integrated blue fluorescence intensity, representative of DNA 
content.  Control cells (gray shaded region) have a primarily unimodal population distribution 
with most cells in the low DNA content range of 400-700 MFU (mostly diploid nuclei).  
Nocadozole treated cells (orange dotted line) show a bimodal distribution with more cells in the 
800-1400 MFU range, indicating polyploidy.  Docetaxel treated cells (blue solid line) appear to 
show a multimodal distribution of cells with abnormal, non-multiplicative DNA content, likely 
illustrating the induction of aneuploidy.   
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Figure 9. Compound DIHI can Revert the Phenotype in Docetaxel- and Nocodazole-treated 
cells.  A-F) 786-0 responses after exposure to various treatments.  Upper panels show cell 
density, middle panels show nuclear area, and bottom panels show nuclear LC3 intensity.  
Markers represent normalized well averages from independent experiments (indicated by 
different marker types).  Control levels of cell density, nuclear area, and nuclear LC3 are 
indicated by the red dashed lines traversing the panels.  A-C) Cells treated with docetaxel, D-F) 
cells treated with nocodazole. A) Increasing docetaxel dose reduces cell density, and increases 
nuclear area increases (asterisks indicate significance in a linear regression). In the presence of 
background docetaxel, DTEP (B) or DIHI (C) were added in increasing doses. D) A nocodazole 
gradient lowers cell density and increases nuclear area through mitotic blockade. Increasing 
doses of the compounds DTEP (E) and DIHI (F). G) Representative confocal images of 786-0 
renal cells exposed to DMSO (top), docetaxel 0.8 µg/mL (DT, middle), or docetaxel and 15 µM 
DIHI (bottom).    
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Discussion 
While some studies have documented nuclear autophagy as a cellular phenomenon, none 
have been able to specifically manipulate the process. We have shown here that nucleophagy is a 
phenotypically specific form of autophagy distinct from macroautophagy and may be implicated 
in the survival of cells under nuclear stress. Additionally, we have utilized two recently-
identified small molecules (DTEP, DIHI) to regulate the amount of LC3 that is present within the 
nucleus. We attempted to elucidate the relationship between nuclear stress and nucleophagy by 
knocking down components of the nuclear import machinery. As expected from previous studies 
(Drake, Kang, and Kenworthy), nuclear importins 7, 8, and β1 do not appear to play a role in 
LC3 nuclear entry.  Instead, the knockdown of these importins led to nuclear stress which 
induced nuclear autophagic puncta. The presence of nucleophagy across multiple cell lines 
suggests that the process is not an artifact confined to a specific subset of cells (Buckingham et 
al.), rather, a distinct stress response pathway that is likely conserved. Nucleophagy is associated 
with an increase in LC3 found in nuclear holes within the nucleus. In the setting of aneuploidy, 
we found that treatment with DIHI, a potential inhibitor of nucleophagy, results in the blockage 
of senescence and an increase in cell numbers (thus undoing the effects of docetaxel). 
 Nuclear-associated autophagy likely encompasses a collection of varied cellular 
mechanisms with diverse functions that may span the activation of senescence, disposal of 
micronuclei, and perhaps even removal incongruous strands of DNA (Dou et al.). Our ability to 
control and disrupt these processes is critical in order to understand their function and 
mechanism, while simultaneously leveraging the process for therapeutic reasons. We 
hypothesize, in accordance with (Dou et al.), DTEP may cause an increase in lamin-degrading 
nucleophagy specifically under the presence of nuclear stress, resulting in the high occurrence of 
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nuclear autophagic puncta observed. Furthermore, (Dou et al. 2015) concludes that an inhibition 
of the nuclear lamina degradation via the knockdown of the basal autophagy gene Atg7 
decreases the rate of degradation of nuclear lamina and prevents the induction of protective 
senescence.  We have discovered a chemical tool, DIHI, which may also inhibit this lamin-
degrading nucleophagy, thus preserving the nucleus, allowing for continued cell division. This 
inhibition allows for an increased potential for oncogenic transformation and an increased risk of 
cancer (Dou et al.).  An alternative hypothesis is that DTEP could be disrupting the completion 
of nucleophagy, causing a buildup of LC3 within the nucleus without subsequently increasing 
autophagic flux.  Based on our measurements of flux with RFP-LC3-GFP, this seems unlikely.  
Future studies utilizing these tools will allow us and others to reveal the complex mechanisms 
underlying nucleophagy.  
Further work is being done to provide additional evidence characterizing nucleophagy 
and the effects of compounds DTEP and DIHI. Biochemical assays, including protein abundance 
analysis of LC3B, importins 7 and 8, as well as Lamin B1 will allow us to determine both 
potential pathways our chemicals target as well as some of the mechanisms of LC3 transport 
during nucleophagy. Additional experiments are also in progress to confirm the legitimacy of the 
aneuploidy phenotype through heterokaryon assays and G-banding.  
Now that nucleophagy has been generally characterized, there are three important 
directions in which further research and investigation may continue.  First, the identity of the 
sensors and signaling networks that activate nucleophagy are still unknown, and substrate 
targeting are not understood.  The egress of nuclear material via nucleophagy has now been 
described in more detail (Dou et al.), but the mechanism by which the autophagic machinery 
enters the nucleus is unclear.  Previous studies  (Drake, Kang, and Kenworthy) suggest LC3 
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enters the nucleus via passive diffusion, but this result is unsatisfying. In the setting of importin 
knockdown (IPO8 specifically), some LC3 that might have other otherwise traversed the nuclear 
envelope was unable to enter the nucleus, implying a partial mode of specific transport by IPO8.  
More studies will have to carefully explore these mechanisms. 
Our second goal queries nucleophagy’s role in disease, including cancer and 
neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and Alzheimer's. 
Various mutations, including the ALS C9orf72 mutant, are known to result in nuclear stress due 
to RAN proteotoxic aggregates and, perhaps more interestingly, the buildup of antisense RNA 
foci within the nucleus (Hayes and Rothstein). The implication of nucleophagy as a potential 
disposal system for these mis-incorporated products may be critical for the survival of cells in 
the onset of these diseases. C9orf72 mutants are known to have irregularities in the structure and 
stability of the nuclear envelope directly related to the length of the repeat, which ultimately 
leads to degeneration of neuronal tissue and failure of the nuclear pore to allow effective 
nucleocytoplasmic transport (Freibaum et al.). Given that recent findings suggest the direct 
connection between C9orf72 and an increase in autophagic flux (Yang et al.), the next logical 
step is to investigate the presence and potential role of nucleophagy in cell survival in the setting 
of ALS and familial frontotemporal dementia (FTD).  
Finally, more research may reveal the prevalence of nucleophagy in the tumor 
microenvironment. Tandem to the role of C9orf72 in autophagy regulation is the influence of 
heterotypic interactions of the tumor microenvironment.  Dysfunctional autophagy is known to 
induce tumorigenesis, making this connect particularly interesting.  Previous research has 
highlighted the role of immune cells (human peripheral blood lymphocytes) in inducing 
autophagy to promote tumor cell survival and proliferation (Buchser et al.). Despite these 
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advances, many questions still remain, including how the surrounding stromal, immune, and 
endothelial cells can affect the specificity and magnitude of nucleophagic flux in tumor cells.  
Furthermore, we would like to ask how this cell mediated behavior can regulate crosstalk within 
the physiological environment to activate and modulate pathways, respond to metabolic stress, 
and maintain homeostasis. Ultimately, looking at these heterotypic orchestrations will give better 
intuition for therapeutic targets that modulate both autophagy and the tumor microenvironment 
to hinder cancer cell progression and metastasis.   
 
 
  
	 36	
Supplemental Figures 
 
 
Supplemental Figure 1.  Plate Layout of Secondary Assay. Perimeter wells left untreated, 
with only media and the diluent (10% DMSO and 90% PBS). Individual compounds of interest 
were added in decreasing doses down the columns, indicated by the separate colored gradients in 
the schematic. The downward gradients represent a serial dilution of the drug from 20µM to 
1.25µM, with the last row (G) left untreated (0µM) as a control.      
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Supplemental Figure 2.  Assay Hierarchy and Tracing.  A) 96-well plates were used 
throughout the entire screening process B) A consistent automated 2x2 imaging pattern was 
established prior to imaging to capture four separate images per well, later stitched together to 
get a complete image of the well via NIS-Elements. C) Images were split into separate fields via 
FIJI/ImageJ software,  then rerouted to CellProfiler to analyze/obtain D) cytometric data on the 
number of LC3 puncta in the nuclei and cytoplasm, nuclear and cytoplasmic LC3 levels, nuclear 
and cytoplasmic masks. 
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Supplemental Figure 3. Correlation analysis of plates and parameter.  Each pair of plates 
from the primary screen was analyzed by comparing it to its replicate directly or by rotating 180 
degrees and comparing.  Each plate was screened twice with separate cell passages. A. 
Individual Plate IDs are compared well-to-well with their replicate.  The displayed value is the 
average of all the measured parameters (listed in B), with standard deviation.  B. Individual 
measured parameters (ranked by best to worst) - x-axes are comparable to A respectively.   
 
 
 
 
 
 
 
  
	 39	
References 
 
Akinduro, Olufolake et al. “Constitutive Autophagy and Nucleophagy during Epidermal 
Differentiation.” The Journal of investigative dermatology (2016): 1–11. Web. 
Amaravadi, Ravi K et al. “Autophagy Inhibition Enhances Therapy-Induced Apoptosis in a Myc 
-Induced Model of Lymphoma.” 117.2 (2007): n. pag. Web. 
Biamonti, Giuseppe, and Claire Vourc’h. “Nuclear Stress Bodies.” Cold Spring Harbor 
perspectives in biology 2.6 (2010): 1–12. Web. 
Buchser, William J et al. “Cell-Mediated Autophagy Promotes Cancer Cell Survival.” Cancer 
Research 72.12 (2012): 2970–2979. Web. 
Buckingham, Erin M et al. “Nuclear LC3-Positive Puncta in Stressed Cells Do Not Represent 
Autophagosomes.” BioTechniques 57.5 (2014): 241–4. Web. 
Carneiro, Leticia A M, and Leonardo H Travassos. “The Interplay between NLRs and 
Autophagy in Immunity and Inflammation The Interplay between NLRs and Autophagy in 
Immunity and Inflammation.” November 2013 (2017): n. pag. Web. 
Codogno, P, and A J Meijer. “Autophagy and Signaling: Their Role in Cell Survival and Cell 
Death.” Cell Death and Differentiation 12 (2005): 1509–1518. Web. 
D’Angelo, Maximiliano A. et al. “Age-Dependent Deterioration of Nuclear Pore Complexes 
Causes a Loss of Nuclear Integrity in Postmitotic Cells.” Cell 136.2 (2009): 284–295. Web. 
Dou, Zhixun et al. “Autophagy Mediates Degradation of Nuclear Lamina.” Nature 527.7576 
(2015): 105–109. Web. 
Drake, Kimberly R, Minchul Kang, and Anne K Kenworthy. “Nucleocytoplasmic Distribution 
and Dynamics of the Autophagosome Marker EGFP-LC3.” PloS one 5.3 (2010): e9806. 
Web. 
Freibaum, Brian D. et al. “GGGGCC Repeat Expansion in C9orf72 Compromises 
Nucleocytoplasmic Transport.” Nature 525.7567 (2015): 129–33. Web. 
Gomes, Ligia C., and Luca Scorrano. “Mitochondrial Morphology in Mitophagy and 
Macroautophagy.” Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1833.1 
	 40	
(2013): 205–212. Web. 
Hayes, Lindsey R., and Jeffrey D. Rothstein. “C9ORF72-ALS/FTD: Transgenic Mice Make a 
Come-BAC.” Neuron 90.3 (2016): 427–431. Web. 
Heo, David et al. Pharmacologic Agents Targeting Manipulating Nucleophagy in Renal Cancer 
Cell Lines. N.p., 2017. Print. 
Hernández-Vargas, H, J Palacios, and G Moreno-Bueno. “Molecular Profiling of Docetaxel 
Cytotoxicity in Breast Cancer Cells: Uncoupling of Aberrant Mitosis and Apoptosis.” 
Oncogene 26.20 (2007): 2902–13. Web. 
Hirano, Makito et al. “ALADINI482S Causes Selective Failure of Nuclear Protein Import and 
Hypersensitivity to Oxidative Stress in Triple A Syndrome.” Proceedings of the National 
Academy of Sciences of the United States of America 103 (2006): 2298–2303. Web. 
Kamentsky, Lee et al. “Improved Structure, Function and Compatibility for Cellprofiler: 
Modular High-Throughput Image Analysis Software.” Bioinformatics 27.8 (2011): 1179–
1180. Web. 
Kimura, Shunsuke, Takeshi Noda, and Tamotsu Yoshimori. “Dissection of the Autophagosome 
Maturation Process by a Novel Reporter Protein, Tandem Fluorescent-Tagged LC3.” 
Autophagy 3.5 (2007): 452–460. Web. 
Klionsky, Daniel J et al. “Guidelines for the Use and Interpretation of Assays for Monitoring 
Autophagy (3rd Edition).” Autophagy 12.1 (2016): 1–222. Web. 
Kose, Shingo, Maiko Furuta, and Naoko Imamoto. “Hikeshi, a Nuclear Import Carrier for 
Hsp70s, Protects Cells from Heat Shock-Induced Nuclear Damage.” Cell 149.3 (2012): 
578–589. Web. 
Kraft, Claudine, Fulvio Reggiori, and Matthias Peter. “Selective Types of Autophagy in Yeast.” 
Biochimica et Biophysica Acta - Molecular Cell Research 1793.9 (2009): 1404–1412. Web. 
Levine, Beth, and Daniel J. Klionsky. “Development by Self-Digestion: Molecular Mechanisms 
and Biological Functions of Autophagy.” Developmental Cell 6.4 (2004): 463–477. Web. 
Liang, X H et al. “Induction of Autophagy and Inhibition of Tumorigenesis by Beclin 1.” Nature 
402.6762 (1999): 672–676. Web. 
	 41	
Lipatova, Zhanna, and Nava Segev. “A Role for Macro-ER-Phagy in ER Quality Control.” 
(2015): 1–29. Web. 
Mah, L-J, a El-Osta, and T C Karagiannis. “gammaH2AX: A Sensitive Molecular Marker of 
DNA Damage and Repair.” Leukemia : official journal of the Leukemia Society of America, 
Leukemia Research Fund, U.K 24.4 (2010): 679–686. Web. 
Marquez, Rebecca T, and Liang Xu. “Bcl-2 : Beclin 1 Complex : Multiple , Mechanisms 
Regulating Autophagy / Apoptosis Toggle Switch.” 2.2 (2012): 214–221. Print. 
Mathew, Robin et al. “Autophagy Suppresses Tumor Progression by Limiting Chromosomal 
Instability.” Baehrecke 2003 (2007): 1367–1381. Web. 
Mijaljica, Dalibor, and Rodney J Devenish. “Nucleophagy at a Glance.” Journal of cell science 
126.Pt 19 (2013): 4325–4330. Web. 
Mijaljica, Dalibor, Mark Prescott, and Rodney J Devenish. “The Intricacy of Nuclear Membrane 
Dynamics during Nucleophagy.” Nucleus 1.3 (2010): 213–223. Web. 
Mizushima, Noboru. “Autophagy : Process and Function.” (2007): 2861–2873. Web. 
Mizushima, Noboru, and Tamotsu Yoshimori. “How to Interpret LC3 Immunoblotting.” 
Autophagy 3.6 (2007): 542–545. Web. 
Park, Young-Eun et al. “Autophagic Degradation of Nuclear Components in Mammalian Cells.” 
Autophagy 5.6 (2009): 795–804. Print. 
Roggero, Vincent R. et al. “Nuclear Import of the Thyroid Hormone Receptor α1 Is Mediated by 
Importin 7, Importin β1, and Adaptor Importin α1.” Molecular and Cellular Endocrinology 
419 (2016): 185–197. Web. 
Rogov, Vladimir et al. “Interactions between Autophagy Receptors and Ubiquitin-like Proteins 
Form the Molecular Basis for Selective Autophagy.” Molecular Cell 53.2 (2014): 167–178. 
Web. 
Santaguida, Stefano et al. “Aneuploidy-Induced Cellular Stresses Limit Autophagic 
Degradation.” Genes and Development 29.19 (2015): 2010–2021. Web. 
Schneider, Caroline a, Wayne S Rasband, and Kevin W Eliceiri. “NIH Image to ImageJ: 25 
Years of Image Analysis.” Nature Methods 9.7 (2012): 671–675. Web. 
	 42	
Schuck, Sebastian, Ciara M Gallagher, and Peter Walter. “ER-Phagy Mediates Selective 
Degradation of Endoplasmic Reticulum Independently of the Core Autophagy Machinery.” 
(2014): 4078–4088. Web. 
Stewart, Murray. “Molecular Mechanism of the Nuclear Protein Import Cycle.” Nature reviews. 
Molecular cell biology 8.3 (2007): 195–208. Web. 
Torres, Eduardo M., Bret R. Williams, and Angelika Amon. “Aneuploidy: Cells Losing Their 
Balance.” Genetics 2008: 737–746. Web. 
Tsuboi, Shigeru. “Autophagy in Yeast Demonstrated with Proteinase-Deficient Mutants and 
Conditions for Its Induction.” 119.2 (1992): 3–8. Print. 
Ugolino, Janet et al. “Loss of C9orf72 Enhances Autophagic Activity via Deregulated mTOR 
and TFEB Signaling.” PLOS Genetics 12.11 (2016): e1006443. Web. 
William J Buchser, Thomas C Laskow, Philip J Pavlik. “Cell-Mediated Autophagy Promotes 
Cancer Cell Survival William.” 72.12 (2013): 2970–2979. Web. 
Wong, Alan S L, Zelda H Cheung, and Nancy Y Ip. “Molecular Machinery of Macroautophagy 
and Its Deregulation in Diseases.” Biochimica et biophysica acta 1812.11 (2011): 1490–7. 
Web. 
Xie, Zhiping, and Daniel J Klionsky. “Autophagosome Formation : Core Machinery and 
Adaptations.” 9.10 (2007): n. pag. Print. 
Yang, Mei et al. “C9ORF72/SMCR8-Containing Complex Regulates ULK1 and Plays a Dual 
Role in Autophagy.” Life Sciences September (2016): 1–18. Web. 
Yang, Zhifen, and Daniel J Klionsky. “Eaten Alive : A History of Macroautophagy.” Nature 
Publishing Group 12.9 (2010): 814–822. Web. 
Yorimitsu, Tomohiro et al. “Endoplasmic Reticulum Stress Triggers Autophagy *.” 281.40 
(2006): 30299–30304. Web. 
Zhang, K et al. “The C9orf72 Repeat Expansion Disrupts Nucleocytoplasmic Transport.” Nature 
525.7567 (2015): 56–61. Web. 
 
